Relapsed/Refractory Sarcomas

specific

A sarcoma that does not respond to treatment.

Centers

Active Trials

$290K

Cancer Funding

Top Centers for Relapsed/Refractory Sarcomas(5)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive High-Volume Research Center	High-Volume Research Center	—	$290K	74.0
2	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		—	—	56.5
3	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive		—	—	56.5
4	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	56.5
5	Boston University Cancer CenterBoston, MA		—	—	56.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →